Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate-Reference-Cited by-同舟云学术

Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate

Published:2018-05 Issue:3 Volume:33 Page:e2658
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum Psychopharmacol Clin Exp

Author:

Girardi Paolo¹^ORCID,Del Casale Antonio¹^ORCID,Rapinesi Chiara¹,Kotzalidis Georgios D.¹,Splendori Francesca¹,Verzura Claudio²,Trovini Giada²,Sorice Serena²,Carrus Dario³,Mancinelli Iginia¹,Comparelli Anna¹,De Filippis Sergio⁴,Francomano Antonio⁵,Ballerini Andrea⁶,Marcellusi Andrea⁷,Mennini Francesco S.⁷,Ducci Giuseppe⁸,Sani Gabriele¹,Pompili Maurizio¹,Brugnoli Roberto¹

Affiliation:

1. Department of Neuroscience, Mental Health, and Sensory Organs (NESMOS); Sapienza University, Faculty of Medicine and Psychology, Sant'Andrea University Hospital; Rome Italy

2. Residency School in Psychiatry; Faculty of Medicine and Psychology, Sapienza University; Rome Italy

3. Mental Health Department; Azienda Sanitaria Locale Viterbo; Viterbo Italy

4. Villa von Siebenthal Neuropsychiatric, Clinic and Hospital; Rome Italy

5. Department of Experimental Biomedicine and Clinical Neuroscience; University of Palermo; Palermo Italy

6. Department of Neuroscience, Psychology, Drug Research and Child Health, Section of Neuroscience; University of Florence; Florence Italy

7. Faculty of Economics, Centre for Economic and International Studies (CEIS)-Economic Evaluation and HTA (EEHTA); Tor Vergata University; Rome Italy

8. Mental Health Department; Azienda Sanitaria Locale Roma 1; Rome Italy

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference48 articles.

1. Paliperidone for the treatment of schizoaffective disorder;Alphs;Expert Opinion on Pharmacotherapy,2016

2. Diagnostic and Statistical Manual of Mental Disorders

3. The burden of schizophrenia on caregivers: A review;Awad;PharmacoEconomics,2008

4. Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory;Bartzokis;Schizophrenia Research,2011

5. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia;Bartzokis;Schizophrenia Research,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Safety of Long-Acting Injectable Antipsychotics: A Systematic Review and Network Meta-Analysis;Psychiatry Investigation;2023-12-25

2. Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria;The Lancet Psychiatry;2023-12

3. Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction;Journal of Clinical Medicine;2023-11-08

4. Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders;Molecular Psychiatry;2023-07-21

5. The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data;Journal of Medical Economics;2023-02-24